P-MAPA

N/A

Report date: 2025/06/11 10:59:36
NME

Base Information

Drug NameP-MAPA
Drug Alias Nameammonium magnesium phospholinoleate-palmitoleate anhydrideSB-73P-MAPAP-MAP
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionToll like receptor 4 agonistsImmunostimulantsToll like receptor 2 agonists
TargetsToll like receptor 4Toll like receptor 2
Therapy Area/IndicationsUrinary Bladder NeoplasmsZika Virus InfectionHIV Infections +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBrazil
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversidade Estadual De Campinas
China Registration ClassN/A

Develop Information

Active CompaniesFarmabrasilisUniversidade Estadual De Campinas
Inactive CompaniesN/A
Active IndicationsUrinary Bladder NeoplasmsZika Virus InfectionSchistosomiasis +[4] 
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A